http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20090081830-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c419906858e635b9c06e115d9e2d37cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
filingDate 2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2e43f3920a0a2a23c39b66f92aeae80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8b3210cc84569c44d2ae0086ee17280
publicationDate 2009-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20090081830-A
titleOfInvention SNP Gene Set for Diagnosing Aspirin-Sensitive Asthma
abstract The present invention is to analyze the relationship between the rate of decrease of Forced Expiratory Volume in one second and single nucleotide polymorphism (SNP) after administration of aspirin, which is the standard for diagnosing aspirin-sensitive asthma. Provided is a set of SNP genes that can be diagnosed. In the present invention, genotyping was performed by selecting 1,536 SNPs from the NCBI SNP DB for the development of a SNP gene set for diagnosing aspirin-sensitive asthma. As a result, a total of 1,420 SNPs were successfully genotyped, and 527 SNPs with a minor allele frequency (MAF) of less than 0.1 and a P-value of multiple regression analysis for FEV1 reduction after aspirin administration were found. Primary SNP gene candidates were selected. A second analysis was performed with staged variable selection to develop a set of 24 SNP genes with high estimates of the FEV1 reduction rate after administration of aspirin of the present invention (P value <0.0001). The SNP gene set of the present invention suggests that aspirin-sensitive asthma can be diagnosed without administration of aspirin, which can be usefully used in new drug development, disease diagnosis, and treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107142307-A
priorityDate 2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211727
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66587205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447882409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452088256
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93573
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454724328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9

Total number of triples: 31.